Tipifarnib and Erlotinib Hydrochloride in Treating Patients With Advanced Solid Tumors
Clinical trial NCT00085553 · COMPLETED
Trial details
- NCT number
- NCT00085553
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-05-20
- Primary completion
- 2008-05-07
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.